About Us
Professional company for 3D cell culture platform specialized in anticancer drug sensitivity and efficacy/toxicity test.
Executive
MBD is growing into a global biotechnology company through innovative technology and differentiated research development.
Advisories
Eun-Ha Kim, Ph.D.
current Assistant Professor, Ajou University
Post doctoral Fellow -Harvard Medical School /
Massachusetts General Hospital
Post doctoral Fellow - Seoul National University
Dong-Hwan Kim, Ph.D.
Professor, Department of Medical Biotechnology, Konyang University
Toxicity Test Research – Donga ST R&D
Development and Nonclinical Study of HNP-2006 - Hana Pharm
Jonathan S. Dordick, Ph.D.
Howard P Isermann Professor of Chemical & Biological Engineering
Professor of Biomedical Engineering and Biological Sciences
C.E.O : Bo Sung Ku Tel : +82-31-888-9500 Fax : +82-31-888-9981
Copyright © 2021 MBD www.mbdbiotech.com All Rights Reserved.